Reviewed,
UniProtKB/Swiss-Prot Q9ULW0 (TPX2_HUMAN)
Last modified
May 26, 2009.
Version 89.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Targeting protein for Xklp2 Alternative name(s): Restricted expression proliferation-associated protein 100 Short name=p100 Differentially expressed in cancerous and non-cancerous lung cells 2 Short name=DIL-2 Protein fls353 Hepatocellular carcinoma-associated antigen 519 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 747 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Subcellular location | Nucleus. Spindle. Note: During mitosis it is strictly associated with the spindle pole and with the mitotic spindle, whereas during S and G2, it is diffusely distributed throughout the nucleus. |
| Tissue specificity | Expressed in lung carcinoma cell lines but not in normal lung tissues. |
| Developmental stage | Exclusively expressed in proliferating cells from the transition G1/S until the end of cytokinesis. |
| Post-translational modification | Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Nucleus |
| Coding sequence diversity | Polymorphism |
| PTM | Phosphoprotein |
| Technical term | 3D-structure |
| Gene Ontology (GO) | |
| Biological process | cell proliferation Ref.1 Traceable author statement. Source: ProtInc mitosis Ref.9Traceable author statement. Source: ProtInc |
| Cellular component | nucleus Ref.9 Traceable author statement. Source: ProtInc spindle Ref.9Traceable author statement. Source: ProtInc |
| Molecular function | ATP binding Ref.1 Traceable author statement. Source: ProtInc GTP binding Ref.1Traceable author statement. Source: ProtInc protein bindingInferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| AURKA | O14965 | 1 | EBI-1037322,EBI-448680 | |
| CRK | P46108 | 1 | EBI-1037322,EBI-886 | |
| GRB2 | P62993 | 1 | EBI-1037322,EBI-401755 | |
| NCK1 | P16333 | 1 | EBI-1037322,EBI-389883 | |
| PIK3R1 | P27986 | 1 | EBI-1037322,EBI-79464 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||
Molecule processing | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 747 | 747 | Targeting protein for Xklp2 | PRO_0000065581 | ||||||||
Amino acid modifications | ||||||||||||
| Modified residue | 51 | 1 | Phosphothreonine Ref.13 | |||||||||
| Modified residue | 59 | 1 | Phosphothreonine Ref.18 | |||||||||
| Modified residue | 72 | 1 | Phosphothreonine Ref.13 Ref.18 | |||||||||
| Modified residue | 121 | 1 | Phosphoserine Ref.13 Ref.15 Ref.17 Ref.18 | |||||||||
| Modified residue | 125 | 1 | Phosphoserine Ref.13 Ref.15 Ref.17 Ref.18 | |||||||||
| Modified residue | 147 | 1 | Phosphothreonine Ref.13 | |||||||||
| Modified residue | 185 | 1 | Phosphoserine Ref.17 | |||||||||
| Modified residue | 186 | 1 | Phosphoserine Ref.13 | |||||||||
| Modified residue | 257 | 1 | Phosphoserine Ref.18 | |||||||||
| Modified residue | 293 | 1 | Phosphoserine Ref.11 Ref.13 Ref.17 | |||||||||
| Modified residue | 310 | 1 | Phosphoserine Ref.18 | |||||||||
| Modified residue | 338 | 1 | Phosphothreonine Ref.13 Ref.18 | |||||||||
| Modified residue | 359 | 1 | Phosphoserine Ref.13 | |||||||||
| Modified residue | 369 | 1 | Phosphothreonine Ref.12 Ref.13 | |||||||||
| Modified residue | 374 | 1 | Phosphothreonine Ref.13 | |||||||||
| Modified residue | 486 | 1 | Phosphoserine Ref.12 Ref.13 Ref.14 Ref.17 Ref.18 | |||||||||
| Modified residue | 542 | 1 | Phosphoserine Ref.13 | |||||||||
| Modified residue | 634 | 1 | Phosphoserine Ref.16 | |||||||||
| Modified residue | 652 | 1 | Phosphoserine Ref.13 | |||||||||
| Modified residue | 654 | 1 | Phosphoserine Ref.13 | |||||||||
| Modified residue | 738 | 1 | Phosphoserine Ref.10 Ref.12 Ref.13 Ref.17 Ref.18 | |||||||||
Natural variations | ||||||||||||
| Natural variant | 464 | 1 | T → N in a colorectal cancer sample; somatic mutation. Ref.19 | VAR_036269 | ||||||||
Experimental info | ||||||||||||
| Sequence conflict | 182 | 1 | K → N in BAA76931. Ref.3 | |||||||||
| Sequence conflict | 273 | 1 | K → E in BAA85893. Ref.1 | |||||||||
| Sequence conflict | 712 | 1 | V → VTGSMSTDEHKHASVLFYLY LTLYQTGSKV Ref.5 | |||||||||
Secondary structure | ||||||||||||
Helix Strand Turn | ||||||||||||
| Helix | 31 – 33 | 3 | ||||||||||
| Helix | 34 – 40 | 7 | ||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display." Manda R., Kohno T., Matsuno Y., Takenoshita S., Kuwano H., Yokota J. Genomics 61:5-14(1999) [PubMed: 10512675] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Assignment of human proliferation associated p100 gene (C20orf1) to human chromosome band 20q11.2 by in situ hybridization." Zhang Y., Heidebrecht H.J., Rott A., Schlegelberger B., Parwaresch R. Cytogenet. Cell Genet. 84:182-183(1999) [PubMed: 10393424] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Fetal gene preferentially expressed in colorectal cancer." Nezu J. Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [4] | "Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies." Wang Y., Han K.-J., Pang X.-W., Vaughan H.A., Qu W., Dong X.-Y., Peng J.-R., Zhao H.-T., Rui J.-A., Leng X.-S., Cebon J., Burgess A.W., Chen W.-F. J. Immunol. 169:1102-1109(2002) [PubMed: 12097419] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Hepatoma. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed: 11780052] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain and Lung. |
| [7] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Blocker H., Heubner D., Hoerlein A., Michel G., Wedler H., Kohrer K., Ottenwalder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 21-747. Tissue: Testis. |
| [8] | "TPX2, a novel Xenopus MAP involved in spindle pole organization." Wittmann T., Wilm M., Karsenti E., Vernos I. J. Cell Biol. 149:1405-1418(2000) [PubMed: 10871281] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 42-747. |
| [9] | "p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M." Heidebrecht H.J., Buck F., Steinmann J., Sprenger R., Wacker H.H., Parwaresch R. Blood 90:226-233(1997) [PubMed: 9207457] [Abstract] Cited for: CHARACTERIZATION. |
| [10] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-738, MASS SPECTROMETRY. Tissue: Epithelium. |
| [11] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293, MASS SPECTROMETRY. Tissue: Epithelium. |
| [12] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-369; SER-486 AND SER-738, MASS SPECTROMETRY. Tissue: Epithelium. |
| [13] | "Phosphoproteome analysis of the human mitotic spindle." Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R. Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006) [PubMed: 16565220] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-51; THR-72; SER-121; SER-125; THR-147; SER-186; SER-293; THR-338; SER-359; THR-369; THR-374; SER-486; SER-542; SER-652; SER-654 AND SER-738, MASS SPECTROMETRY. Tissue: Epithelium. |
| [14] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, MASS SPECTROMETRY. Tissue: Epithelium. |
| [15] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-125, MASS SPECTROMETRY. |
| [16] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-634, MASS SPECTROMETRY. |
| [17] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121; SER-125; SER-185; SER-293; SER-486 AND SER-738, MASS SPECTROMETRY. |
| [18] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-59; THR-72; SER-121; SER-125; SER-257; SER-310; THR-338; SER-486 AND SER-738, MASS SPECTROMETRY. |
| [19] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] ASN-464. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AB027467 mRNA. Translation: BAA85893.1. AF098158 mRNA. Translation: AAF03248.1. AB024704 mRNA. Translation: BAA76931.1. AF146731 mRNA. Translation: AAD33965.1. AL160175 Genomic DNA. Translation: CAD38007.1. BC004136 mRNA. Translation: AAH04136.1. BC020207 mRNA. Translation: AAH20207.1. AL117534 mRNA. Translation: CAB55982.1. AF244547 mRNA. Translation: AAF81695.1. | |||||||||||||||||||
| IPI | IPI00008477. | ||||||||||||||||||
| PIR | T17292. | ||||||||||||||||||
| RefSeq | NP_036244.2. | ||||||||||||||||||
| UniGene | Hs.244580 Hs.708960 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | Q9ULW0. 5 interactions. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q9ULW0. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PRIDE | Q9ULW0. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSG00000088325. Homo sapiens. [Contig view] | ||||||||||||||||||
| GeneID | 22974. | ||||||||||||||||||
| KEGG | hsa:22974. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| GeneCards | GC20P029790. | ||||||||||||||||||
| H-InvDB | HIX0015714. | ||||||||||||||||||
| HGNC | HGNC:1249. TPX2. | ||||||||||||||||||
| HPA | HPA005487. | ||||||||||||||||||
| MIM | 605917. gene. | ||||||||||||||||||
| PharmGKB | PA25638. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOVERGEN | Q9ULW0. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | aurora_a_pathway. Aurora A signaling. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q9ULW0. | ||||||||||||||||||
| Bgee | Q9ULW0. | ||||||||||||||||||
| CleanEx | HS_TPX2. | ||||||||||||||||||
| GermOnline | ENSG00000088325. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR015128. Aurora-A_bd. IPR009675. TPX2. [Graphical view] | ||||||||||||||||||
| Pfam | PF09041. Aurora-A_bind. 1 hit. PF06886. TPX2. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| NextBio | 43781. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | TPX2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9ULW0 Secondary accession number(s): Q9H1R4 Q9Y2M1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |

Clusters with


